These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 38499823)

  • 1. The AI-driven Drug Design (AIDD) platform: an interactive multi-parameter optimization system integrating molecular evolution with physiologically based pharmacokinetic simulations.
    Jones J; Clark RD; Lawless MS; Miller DW; Waldman M
    J Comput Aided Mol Des; 2024 Mar; 38(1):14. PubMed ID: 38499823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial intelligence in small molecule drug discovery from 2018 to 2023: Does it really work?
    Lv Q; Zhou F; Liu X; Zhi L
    Bioorg Chem; 2023 Dec; 141():106894. PubMed ID: 37776682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep generative models for ligand-based de novo design applied to multi-parametric optimization.
    Perron Q; Mirguet O; Tajmouati H; Skiredj A; Rojas A; Gohier A; Ducrot P; Bourguignon MP; Sansilvestri-Morel P; Do Huu N; Gellibert F; Gaston-Mathé Y
    J Comput Chem; 2022 Apr; 43(10):692-703. PubMed ID: 35218219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hit Identification Driven by Combining Artificial Intelligence and Computational Chemistry Methods: A PI5P4K-β Case Study.
    Wei L; Xu M; Liu Z; Jiang C; Lin X; Hu Y; Wen X; Zou R; Peng C; Lin H; Wang G; Yang L; Fang L; Yang M; Zhang P
    J Chem Inf Model; 2023 Aug; 63(16):5341-5355. PubMed ID: 37549337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial Intelligence, Machine Learning, and Deep Learning in Real-Life Drug Design Cases.
    Muller C; Rabal O; Diaz Gonzalez C
    Methods Mol Biol; 2022; 2390():383-407. PubMed ID: 34731478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-objective optimization methods in novel drug design.
    Lambrinidis G; Tsantili-Kakoulidou A
    Expert Opin Drug Discov; 2021 Jun; 16(6):647-658. PubMed ID: 33353441
    [No Abstract]   [Full Text] [Related]  

  • 7. Application of Computational Biology and Artificial Intelligence in Drug Design.
    Zhang Y; Luo M; Wu P; Wu S; Lee TY; Bai C
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial intelligence to deep learning: machine intelligence approach for drug discovery.
    Gupta R; Srivastava D; Sahu M; Tiwari S; Ambasta RK; Kumar P
    Mol Divers; 2021 Aug; 25(3):1315-1360. PubMed ID: 33844136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Has Artificial Intelligence Impacted Drug Discovery?
    Patronov A; Papadopoulos K; Engkvist O
    Methods Mol Biol; 2022; 2390():153-176. PubMed ID: 34731468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FSM-DDTR: End-to-end feedback strategy for multi-objective De Novo drug design using transformers.
    Monteiro NRC; Pereira TO; Machado ACD; Oliveira JL; Abbasi M; Arrais JP
    Comput Biol Med; 2023 Sep; 164():107285. PubMed ID: 37557054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial intelligence in drug design.
    Zhong F; Xing J; Li X; Liu X; Fu Z; Xiong Z; Lu D; Wu X; Zhao J; Tan X; Li F; Luo X; Li Z; Chen K; Zheng M; Jiang H
    Sci China Life Sci; 2018 Oct; 61(10):1191-1204. PubMed ID: 30054833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generative machine learning for de novo drug discovery: A systematic review.
    Martinelli DD
    Comput Biol Med; 2022 Jun; 145():105403. PubMed ID: 35339849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial intelligence in molecular de novo design: Integration with experiment.
    Janet JP; Mervin L; Engkvist O
    Curr Opin Struct Biol; 2023 Jun; 80():102575. PubMed ID: 36966692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemistry42: An AI-Driven Platform for Molecular Design and Optimization.
    Ivanenkov YA; Polykovskiy D; Bezrukov D; Zagribelnyy B; Aladinskiy V; Kamya P; Aliper A; Ren F; Zhavoronkov A
    J Chem Inf Model; 2023 Feb; 63(3):695-701. PubMed ID: 36728505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Pareto Algorithm for Efficient De Novo Design of Multi-functional Molecules.
    Daeyaert F; Deem MW
    Mol Inform; 2017 Jan; 36(1-2):. PubMed ID: 28124835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of ADME characteristics in drug discovery and their in silico evaluation: in silico screening of chemicals for their metabolic stability.
    Gombar VK; Silver IS; Zhao Z
    Curr Top Med Chem; 2003; 3(11):1205-25. PubMed ID: 12769701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo molecular design and generative models.
    Meyers J; Fabian B; Brown N
    Drug Discov Today; 2021 Nov; 26(11):2707-2715. PubMed ID: 34082136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial Intelligence in Drug Design.
    Hessler G; Baringhaus KH
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30279331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial Intelligence in Drug Discovery: A Bibliometric Analysis and Literature Review.
    He B; Guo J; Tong HHY; To WM
    Mini Rev Med Chem; 2024; 24(14):1353-1367. PubMed ID: 38243944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecule evoluator. An interactive evolutionary algorithm for the design of drug-like molecules.
    Lameijer EW; Kok JN; Bäck T; Ijzerman AP
    J Chem Inf Model; 2006; 46(2):545-52. PubMed ID: 16562982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.